This inventor holds 1 USPTO granted patent and 4 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignee: Shanghai Benemae Pharmaceutical Corporation. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Yajun Zuo: Innovator in Pharmaceutical Science
Introduction
Yajun Zuo is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical science, particularly in the development of modified exendins and their applications.
Latest Patents
Yajun Zuo holds a patent for "PEG modified exendin or exendin analog and compositions and use thereof." This patent involves exendins or exendin analogs that are modified by one or more PEG derivatives. These derivatives can be linked to one or more amino acids of the exendins or exendin analogs. The patent also describes compositions that include the PEG derivative modified exendin or exendin analog, along with methods for making or administering these modified compounds and their various uses.
Career Highlights
Yajun Zuo is associated with Shanghai Benemae Pharmaceutical Corporation, where he continues to advance his research and innovations. His work focuses on enhancing the efficacy of pharmaceutical compounds through innovative modifications.
Collaborations
Yajun Zuo collaborates with talented professionals in his field, including Wenchao Bao and Hongjing Xu, who contribute to his research endeavors.
Conclusion
Yajun Zuo's innovative work in the pharmaceutical industry exemplifies the impact of scientific research on healthcare. His contributions through patents and collaborations continue to shape advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile